QR 코드를 스캔하여 다운로드하세요.
BTC $75,036.78 +0.14%
ETH $2,340.23 -0.51%
BNB $629.35 +0.77%
XRP $1.44 +1.84%
SOL $88.37 +3.34%
TRX $0.3261 +0.14%
DOGE $0.0980 +1.61%
ADA $0.2557 +2.07%
BCH $449.73 +1.61%
LINK $9.44 +1.85%
HYPE $43.78 -3.49%
AAVE $113.87 +6.67%
SUI $0.9870 +0.57%
XLM $0.1666 +3.60%
ZEC $333.69 -2.82%
BTC $75,036.78 +0.14%
ETH $2,340.23 -0.51%
BNB $629.35 +0.77%
XRP $1.44 +1.84%
SOL $88.37 +3.34%
TRX $0.3261 +0.14%
DOGE $0.0980 +1.61%
ADA $0.2557 +2.07%
BCH $449.73 +1.61%
LINK $9.44 +1.85%
HYPE $43.78 -3.49%
AAVE $113.87 +6.67%
SUI $0.9870 +0.57%
XLM $0.1666 +3.60%
ZEC $333.69 -2.82%

Sonnet Biotherapeutics가 주주 승인을 받아 Hyperliquid Strategies Inc와 사업 합병을 진행합니다

2025-12-02 22:26:45
수집

시장 소식에 따르면, 나스닥 상장 생명공학 회사 Sonnet Biotherapeutics가 주주 승인을 받아 Hyperliquid Strategies Inc와 사업 합병을 추진하고 있습니다.

이전 소식에 따르면, Hyperliquid Strategies는 S-1 문서를 제출하여 최대 10억 달러를 모금하거나 HYPE 토큰을 구매할 계획입니다.

app_icon
ChainCatcher Building the Web3 world with innovations.